Arkolith/Insider Trading/TENX/Form 4

Rich Stuart

Chief Medical Officer, DirectorTENAX THERAPEUTICS, INC. (TENX) · full profile →Form 4 · filed Dec 5, 2025
Net Buying
Open-Market Buys
$46K
Open-Market Sells
$0
Net Open-Market Flow
$46K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2025Buy(P)3K$9.20$23K3K
Dec 3, 2025Buy(P)2K$9.08$14K3K
Dec 2, 2025Buy(P)1K$9.01$9K1K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001841785-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML